BCO vs MATX

The Brink's Company (BCO) shows mixed financial health with a weak Piotroski F-Score of 4/9, indicating borderline stability, and lacks an Altman Z-Score for distress risk assessment. While profitability metrics like ROE (44.40%) and strong earnings growth (YoY +32.70%) are impressive, the extremely high debt/equity ratio (10.89) raises serious concerns about financial leverage. The stock trades at a premium to the Graham Number ($23.89) and a high P/E of 31.92, though below sector average, supported by solid earnings momentum and analyst target of $133.50. However, bearish insider activity and weak technical trend (10/100) counterbalance the bullish fundamentals and growth trajectory.

MATX exhibits exceptional financial health with a Piotroski F-Score of 8/9, indicating strong operational efficiency and balance sheet stability. While the current price ($173.35) sits slightly above the Graham Number ($167.93), it remains significantly undervalued relative to its growth-based intrinsic value of $407.4. Despite a recent decline in revenue growth (-4.30%), the company has maintained strong earnings growth (21.20%) and a consistent track record of beating EPS estimates. The primary headwinds are bearish insider sentiment and a critical regulatory dependency on the Jones Act.